Our articles keep health professionals up-to-date with the happenings throughout the industry.
Scroll

Clinical Articles

HPS Pharmacies prides itself on providing innovative and informative support to assist in the diverse range of issues health professionals face on a day-to-day basis, and to facilitate the distribution of this information for a variety of sectors within the healthcare industry.

HPS’ clinical articles are written by HPS Pharmacies’ experienced and knowledgeable staff and are peer-reviewed by specialist leaders in their field to ensure the accuracy of the information provided. The resourceful and diverse range of articles play an integral role in keeping all health professionals up-to-date with the happenings throughout the industry on a regular basis.

Drugs in Sport

Clinical Article

Your patients will sometimes ask you about whether or not a particular medicine or supplement is permitted in sport. This might seem a trivial question, but to the person asking it is a very…

Read more

Treatment of Infantile Haemangioma

Clinical Article

Also known as a strawberry naevus, an infantile haemangioma is a proliferative benign tumour affecting the cutaneous blood vessels, in which the endothelial cells lining the vessels proliferate in an overgrowth manner. A haemangioma…

Read more

Abemaciclib for Breast Cancer

Clinical Article

On the 1st of January 2020 abemaciclib became listed on the Pharmaceutical Benefits Scheme (PBS) for first-line treatment for non-premenopausal people newly diagnosed with hormone receptor positive, HER2-negative locally advanced or metastatic breast cancer,…

Read more

Primary Cutaneous T-cell Lymphoma

Clinical Article

Primary Cutaneous T-cell Lymphoma is a rare type of non-Hodgkin’s lymphoma (approximately 0.8 in 100,000 in Western countries). They are complex, heterogeneous and characterised by localisation of neoplastic T-lymphocytes to the skin. CD30 positive…

Read more

Gliflozins and Heart Failure

Clinical Article

“Gliflozins”, or sodium-glucose co-transporter 2 (SGLT2) inhibitors, are the newest class of oral anti-diabetic medications. Dapagliflozin was the first agent in this class to be approved for use in diabetes in 2012 (by both…

Read more

Remdesivir – an emerging treatment for COVID-19 patients.

Clinical Article

Introduction: By July 23rd, 2020 there were 15,117,078 SARS-CoV-2 infections, resulting in 620,033 deaths. Prompted by the unrelenting progress of the pandemic, and based upon new research from Beigel et al., the Therapeutic Goods…

Read more
Load More

October 2020

Drugs in Sport (Oct. 09 2020)

September 2020

August 2020

February 2020

Xerostomia (Feb. 27 2020)

Monoclonal Antibodies for Migraine (Feb. 13 2020)

January 2020

Changes to Neural Connector Devices (Jan. 30 2020)

Venetoclax (Jan. 16 2020)

Biosimilars in Oncology (Jan. 03 2020)

October 2019

Lamotrigine Dose Escalation (Oct. 25 2019)

Wilson Disease (Oct. 11 2019)

September 2019

August 2019

July 2019

February 2019

January 2019

Biofilms (Jan. 18 2019)

Medications and Sun Exposure (Jan. 04 2019)

December 2018

November 2018

April 2018

March 2018

February 2018

Antihypertensives in Review (Feb. 16 2018)

Contact Dermatitis (Feb. 02 2018)

January 2018

September 2017

June 2017

April 2017

Management of Psoriasis (Apr. 27 2017)

Grains: Friends or Foes? (Apr. 12 2017)

February 2017

July 2016

May 2016

To Quit or not to Quit (May. 26 2016)

Herbs and Liver Enzymes (May. 12 2016)

April 2016

Infective Endocarditis (Apr. 28 2016)

Febuxostat in chronic gout (Apr. 14 2016)

November 2015

October 2015

Brentuximab Vedotin (Oct. 29 2015)

Tapentadol (Oct. 15 2015)

Bexsero® (Oct. 01 2015)

June 2015

Bell’s Palsy (Jun. 25 2015)

In A PINCH(S) (Jun. 11 2015)

February 2015

November 2014

April 2014

January 2014

Thyroxine Drug Interactions (Jan. 23 2014)

Anaphylaxis (Jan. 12 2014)

November 2013

MedsCheck in Hospitals (Nov. 28 2013)

Antibiotic Awareness Week (Nov. 14 2013)

October 2013

March 2013

ACE and ARB Combination (Mar. 20 2013)